LRIG3 and central nervous system cancer: Figure 7B demonstrated that the tumors in the experimental groups overexpressing LRIG3 and sLRIG3 grew slower than those in the control group. These results indicate that LRIG3 and sLRIG3 ameliorate growth and tumorigenesis of glioma cells in vivo.